Does low T3 signaling raise triglycerides by reducing hepatic lipid metabolism and clearance of triglyceride-rich lipoproteins?

Thyroid hormones, particularly triiodothyronine (T3), serve as master regulators of lipid metabolism. Deficient T3 signaling, whether through clinical hypothyroidism or functional impairment, disrupts the balance between lipid production and removal, typically resulting in elevated serum triglycerides.

Clinical and effectiveness evidence

The relationship between thyroid status and lipid profiles is well-documented in clinical literature. Hypothyroidism is a recognized secondary cause of hypertriglyceridemia, as T3 is essential for the activation of enzymes that break down fats. In patients with low thyroid function, studies consistently show an accumulation of triglyceride-rich lipoproteins. However, research in "euthyroid" individuals (those within normal lab ranges) reveals a nuanced feedback loop: higher T3 levels are sometimes correlated with higher triglycerides as a compensatory response to metabolic stress or obesity. Despite this, the pathological state of low T3 signaling is firmly associated with impaired lipid processing.

Mechanistic explanations

T3 regulates triglycerides through several distinct hepatic and systemic pathways:

• Fatty Acid Oxidation: T3 upregulates the expression of carnitine palmitoyltransferase 1A (CPT1A). This enzyme is the rate-limiting step for mitochondrial $\beta$-oxidation, the process by which the liver burns fatty acids. Low T3 signaling reduces this "burning" capacity, leaving more fatty acids available to be packaged into Very-Low-Density Lipoproteins (VLDL) and secreted into the blood.
• Receptor-Mediated Clearance: T3 directly stimulates the transcription of the Low-Density Lipoprotein Receptor (LDLR) and the Lipoprotein Receptor-related Protein 1 (LRP1). These receptors are responsible for clearing VLDL remnants and other triglyceride-rich particles from circulation. When T3 signaling is low, receptor density drops, causing these particles to linger in the bloodstream.
• Lipoprotein Lipase (LPL) Activity: Thyroid signaling is required for the optimal activity of LPL, the enzyme responsible for stripping triglycerides from lipoproteins so they can be used by tissues. Low T3 leads to sluggish LPL activity, directly contributing to high circulating triglyceride levels.

Bottom line

Low functional T3 signaling raises triglycerides by simultaneously increasing the liver's secretion of VLDL and decreasing the body's ability to clear these particles via the LDLR and LRP1 pathways. This makes optimizing thyroid signaling a critical component of managing lipid disorders.